Aly Safwat A, Zurakowski David, Glass Penny, Skurow-Todd Kami, Jonas Richard A, Donofrio Mary T
Department of Pediatrics, Children's National Medical Center, Washington, District of Columbia, USA.
Departments of Anesthesia and Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Congenit Heart Dis. 2017 Mar;12(2):188-195. doi: 10.1111/chd.12426. Epub 2016 Nov 10.
There are no well-established noninvasive biomarkers for identifying patients at risk for poor outcome after surgery for congenital heart disease. Few studies have assessed prognostic accuracy of cerebral tissue oxygenation index (cTOI) measured by near infrared spectroscopy (NIRS).
To assess the utility of noninvasive NIRS monitoring as a predictor of outcomes after neonatal cardiac surgery through measurement of cTOI. To examine the utility of noninvasive NIRS monitoring in combination with lactate concentration and inotropic score in prediction of outcomes after neonatal cardiac surgery.
Prospective longitudinal cohort study.
Operating room and cardiac intensive care unit, Children's National Heart Institute.
Seventy-five patients with complex congenital heart disease undergoing surgical repair within first month of life.
Cerebral TOI, blood lactate, and inotropic scores were measured preoperative, intraoperative and up to 24 hours postoperative.
Postoperative mortality and neurodevelopmental outcome assessed by the Bayley Scales of Infant Development (BSID II). Mental and motor scores were obtained at 6, 15, and 21 months. Good outcome was defined as survival and BSID mental and motor scores ≥70 points. Poor outcome was defined as death or BSID scores <70 at most recent follow-up.
Cohort of 75 patients prospectively followed including 40 patients with single ventricle and 35 with two ventricles. Four patients died before discharge and ten died within 21 months. Seven patients were lost to follow-up. Among survivors with follow-up (n = 54), BSID was abnormal in 25 (46%). Patients with poor outcome (n = 39) had lower mean cTOI 60 minutes off-CPB (48% vs. 58%, P = .003) and 24 hours postoperative (49% vs. 59%, P < .001), higher lactate (8.2 vs. 5.0 mmol/L, P = .005) and higher inotropic scores (10 vs. 6, P = .02) at 24 hours postoperative. ROC analysis indicated that cTOI had moderate predictive accuracy of outcome (AUC = 0.751, P < .001). Multivariable regression analysis confirmed that predictive accuracy was improved using both cTOI and lactate at 24 hours postoperative (AUC = 0.813, 95% CI: 0.705-0.921, P < .001) with optimal cutoff values <58% and >7.4 mmol/L, respectively (sensitivity = 95%).
Cerebral TOI combined with lactate at 24 hours postoperative are accurate non-invasive predictive biomarkers of patient survival and neurodevelopmental outcome in neonates with CHD undergoing cardiac surgery.
目前尚无成熟的非侵入性生物标志物可用于识别先天性心脏病手术后预后不良的患者。很少有研究评估通过近红外光谱(NIRS)测量的脑组织氧合指数(cTOI)的预后准确性。
通过测量cTOI评估非侵入性NIRS监测作为新生儿心脏手术后预后预测指标的效用。研究非侵入性NIRS监测联合乳酸浓度和肌力评分在预测新生儿心脏手术后预后中的效用。
前瞻性纵向队列研究。
儿童国家心脏研究所手术室和心脏重症监护病房。
75例在出生后第一个月内接受手术修复的复杂先天性心脏病患者。
术前、术中及术后24小时内测量脑组织氧合指数(cTOI)、血乳酸和肌力评分。
通过贝利婴儿发育量表(BSID II)评估术后死亡率和神经发育结局。在6、15和21个月时获得智力和运动评分。良好结局定义为存活且BSID智力和运动评分≥70分。不良结局定义为死亡或在最近一次随访时BSID评分<70分。
对75例患者进行前瞻性随访,其中包括40例单心室患者和35例双心室患者。4例患者在出院前死亡,10例在21个月内死亡。7例患者失访。在有随访的幸存者中(n = 54),25例(46%)的BSID异常。不良结局患者(n = 39)在体外循环停机60分钟时(48%对58%,P = 0.003)和术后24小时(49%对59%,P < 0.001)的平均cTOI较低,术后24小时乳酸水平较高(8.2对5.0 mmol/L,P = 0.005),肌力评分较高(10对6,P = 0.02)。ROC分析表明,cTOI对结局具有中等预测准确性(AUC = 0.751,P < 0.001)。多变量回归分析证实,术后24小时同时使用cTOI和乳酸可提高预测准确性(AUC = 0.813,95%CI:0.705 - 0.921,P < 0.001),最佳截断值分别为<58%和>7.4 mmol/L(敏感性 = 95%)。
术后24小时的脑组织氧合指数(cTOI)联合乳酸是接受心脏手术的先天性心脏病新生儿患者生存和神经发育结局的准确非侵入性预测生物标志物。